Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[IgA nephropathy].

Eric Alamartine1

  • 1Service de néphrologie, dialyse et transplantation rénale, hôpital Nord, 42055 Saint-Etienne Cedex 02. eric.alamartine@chu-st-etienne.fr

La Revue Du Praticien
|March 11, 2004
PubMed
Summary

IgA nephropathy is a common kidney disease affecting young adults, potentially leading to kidney failure. Early detection through routine screening and lifelong medical management are crucial for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.

Journal of the American Society of Nephrology : JASN·2024
Same author

Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy.

Kidney international reports·2024
Same author

Circulating alternative pathway complement cleavage factor Bb is associated with vascular lesions and outcomes in IgA nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023
Same author

Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023
Same author

Nonskeletal and skeletal effects of high doses versus low doses of vitamin D<sub>3</sub> in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023
Same author

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).

BMJ open·2022

Area of Science:

  • Nephrology
  • Immunology

Context:

  • IgA nephropathy (IgAN) is a prevalent glomerular kidney disease.
  • Characterized by indolent progression, it affects young adults.
  • Leads to end-stage renal failure in 20-30% of cases within two decades.

Purpose:

  • To provide an overview of IgA nephropathy.
  • Highlight key prognostic factors and management strategies.

Summary:

  • Microscopic hematuria and proteinuria are more common than gross hematuria.
  • Major prognostic factors include proteinuria, hypertension, and pathological damage.
  • Management focuses on controlling proteinuria and hypertension, with ACE inhibitors or ARBs as central therapies.
  • Steroid and immunosuppressive therapy benefit high-risk patients.

Impact:

  • Emphasizes the need for routine screening for early detection.
  • Underscores the importance of lifelong medical monitoring for IgA nephropathy patients.
  • Informs treatment strategies targeting key prognostic factors to slow disease progression.

Related Experiment Videos